Goodwill and Other Intangible Assets (Tables)
|
3 Months Ended |
Jul. 30, 2021 |
|---|
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Changes in the Carrying Amount of Goodwill |
The following table presents the changes in the carrying amount of goodwill by segment: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | Cardiovascular | | Medical Surgical | | Neuroscience | | Diabetes | | Total | | April 30, 2021 | $ | 7,209 | | | $ | 21,195 | | | $ | 11,300 | | | $ | 2,257 | | | $ | 41,961 | | | | | | | | | | | | | Purchase accounting adjustments | 26 | | | — | | | 3 | | | (2) | | | 27 | | | Currency translation and other | (17) | | | (203) | | | (48) | | | — | | | (268) | | | July 30, 2021 | $ | 7,218 | | | $ | 20,992 | | | $ | 11,255 | | | $ | 2,255 | | | $ | 41,720 | |
|
| Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets |
The following table presents the gross carrying amount and accumulated amortization of intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | July 30, 2021 | | April 30, 2021 | | (in millions) | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization | | Definite-lived: | | | | | | | | | Customer-related | $ | 17,010 | | | $ | (6,296) | | | $ | 17,036 | | | $ | (6,058) | | | Purchased technology and patents | 10,687 | | | (5,143) | | | 11,286 | | | (5,156) | | | Trademarks and tradenames | 475 | | | (255) | | | 475 | | | (251) | | | Other | 78 | | | (60) | | | 82 | | | (68) | | | Total | $ | 28,250 | | | $ | (11,754) | | | $ | 28,879 | | | $ | (11,533) | | | Indefinite-lived: | | | | | | | | | IPR&D | $ | 394 | | | $ | — | | | $ | 394 | | | $ | — | | | | | | | | | |
|
| Gross Carrying Amount of Indefinite-Lived Intangible Assets |
The following table presents the gross carrying amount and accumulated amortization of intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | July 30, 2021 | | April 30, 2021 | | (in millions) | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization | | Definite-lived: | | | | | | | | | Customer-related | $ | 17,010 | | | $ | (6,296) | | | $ | 17,036 | | | $ | (6,058) | | | Purchased technology and patents | 10,687 | | | (5,143) | | | 11,286 | | | (5,156) | | | Trademarks and tradenames | 475 | | | (255) | | | 475 | | | (251) | | | Other | 78 | | | (60) | | | 82 | | | (68) | | | Total | $ | 28,250 | | | $ | (11,754) | | | $ | 28,879 | | | $ | (11,533) | | | Indefinite-lived: | | | | | | | | | IPR&D | $ | 394 | | | $ | — | | | $ | 394 | | | $ | — | | | | | | | | | |
|
| Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets |
Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at July 30, 2021, excluding any possible future amortization associated with acquired IPR&D which has not yet met technological feasibility, is as follows: | | | | | | | (in millions) | Amortization Expense | | Remaining 2022 | $ | 1,286 | | | 2023 | 1,654 | | | 2024 | 1,619 | | | 2025 | 1,597 | | | 2026 | 1,583 | | | 2027 | 1,558 | | | |
|